Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
We recently reported that differentiation of CD8(+) T cells from the naïve to the effector state involves the upregulation of glucose-dependent metabolism. Glucose deprivation or inhibition of glycolysis by 2-deoxy-D-glucose (2-DG) selectively inhibited production of IFN-gamma but not of IL-2. To determine a more global role of glucose metabolism on effector T-cell function, we performed gene array analysis on CD8(+) effector T cells stimulated in the presence or absence of 2-DG. We observed that expression of only 10% of genes induced by TCR/CD28 signaling was inhibited by 2-DG. Among these were genes for key cytokines, cell cycle molecules, and cytotoxic granule proteins. Consistent with these results, production of IFN-gamma and GM-CSF, cell cycle progression, upregulation of cyclin D2 protein, cytolytic activity, and upregulation of granzyme B protein and also conjugate formation were exquisitely glucose-dependent. In contrast to glucose, oxygen was little utilized by CD8(+) effector T cells, and relative oxygen deprivation did not inhibit these CTL functional properties. Our results indicate a particularly critical role for glucose in regulating specific effector functions of CD8(+) T cells and have implications for the maintenance of the effector phase of cellular immune responses in target tissue microenvironments such as a solid tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduction in mTOR activity diminishes IFNγ transcripts in T cells, mitigating Th1 CD4+ T cell differentiation [227, 228, 229].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [227]
In the citing paper
“Limiting glucose levels leads to cellular competition; this impairs T‐cell function via decreased mTOR signaling.”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579 · cited 1×
“To determine which phase of the cell cycle is blocked by 2-DG, we examined the DNA content of stimulated effector cells by PI staining (Nicoletti assay) [6].”
MethodModel-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133 · cited 1×
“Subsequent data analysis involved: i) the normalization of array values by dCHIP software [29], ii) the averaging of two independent samples for each experiment, iii) determining relative expression using normalized values in a Microsoft Excel spreadsheet.”
MethodThree-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968 · cited 1×
“In addition, the mature synapse in many systems includes central clearing of talin and partitioning of signaling molecules such as PKC-θ in the central supramolecular activation cluster (cSMAC) [5].”
BackgroundAMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
The Role of Oxidative Stress in Carcinogenesis
Klaunig, J. E., & Kamendulis, L. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121851 · Cited by 1,533 · cited 1×
“It is well-established that ROS induce DNA damage and can lead to aberrant activation of AP-1 and NF-κB [22].”
BackgroundMolecular and Functional Profiling of Memory CD8 T Cell Differentiation
Kaech, S. M., Hemby, S., Kersh, E., & Ahmed, R. (2002) · Cell · doi:10.1016/s0092-8674(02)01139-x · Cited by 982 · cited 1×
“expression of glycolytic enzyme genes in effector and memory T cells analyzed ex vivo [20].”
BackgroundFuel feeds function: energy metabolism and the T-cell response
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1710 · Cited by 853 · cited 1×
“The role of cell metabolism in T cell responsiveness to TCR/CD28 ligation has recently been reviewed [3].”
BackgroundThe Immunological Synapse of CTL Contains a Secretory Domain and Membrane Bridges
Stinchcombe, J. C., Bossi, G., Booth, S., & Griffiths, G. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00234-5 · Cited by 814
Localization of the primary metabolic block produced by 2-deoxyglucose
Wick, A. N., Drury, D. R., Nakada, H. I., Wolfe, J. B., Britton, B., & Grabowski, R. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64988-9 · Cited by 780 · cited 1×
“5-SHG and 2-DG are both competitive inhibitors of glucose for the glycolytic proteins hexokinase, phosphoglucoisomerase, and phosphoglucomutase [8,9].”
BackgroundRegulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518 · cited 1×
“Hypoxic conditions are known to induce upregulation of HIF-1α, which promotes expression of genes encoding glycolytic enzymes but also has other physiologic targets [17].”
Background
Cited by
Items 201–300 of 387
Contribution of Macrophages and T Cells in Skeletal Metastasis
Mendoza‐Reinoso, V., McCauley, L. K., & Fournier, P. G. J. (2020) · Cancers · doi:10.3390/cancers12041014 · Cited by 37
“As a consequence of this glucose deprivation, the function of T cells is affected, leading to their anergy or to their apoptosis, and loss of effector function, such as decrease of granzyme B, perforin, and IFN-γ for cytotoxic CD8+ T cells [300].”
BackgroundTumor-derived factors affecting immune cells
Russo, V. E. A., & Protti, M. P. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.005 · Cited by 36
Davern, M., Donlon, N. E., O’Connell, F., Gaughan, C., O’Donovan, C., McGrath, J., Sheppard, A. D., Hayes, C., King, R., Temperley, H. C., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04440-0 · Cited by 35
“demonstrated that glucose deprivation or inhibition of glycolysis by 2-deoxy-D-glucose inhibited the production of IFN-γ, GM-CSF, cytotoxic granule proteins and cell cycle progression by T cells derived from healthy donors (Cham et al. 2008).”
BackgroundDimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease
Sangineto, M., Grabherr, F., Adolph, T. E., Grander, C., Reider, S., Jaschke, N., Mayr, L., Schwärzler, J., Dallio, M., Moschen, A. R., et al. (2020) · Liver International · doi:10.1111/liv.14483 · Cited by 33
Schnell, A., Schmidl, C., Herr, W., & Siska, P. J. (2018) · Biomedicines · doi:10.3390/biomedicines6010025 · Cited by 36
“In this regard, tumor metabolic activity may be seen as a barrier to effective immune cell engagement [35], reviewed in [36].”
BackgroundTaming metabolic competition via glycolysis inhibition for safe and potent tumor immunotherapy
Lei, J., Yang, Y., Lu, Z., Pan, H., Fang, J., Jing, B., Chen, Y., & Yin, L. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115153 · Cited by 33
Hu, W., Li, F., Liang, Y., Liu, S., Wang, S., Shen, C., Zhao, Y., Wang, H., & Zhang, Y. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010540 · Cited by 42
“Detailed procedures are provided in online supplemental file 2.”
Gracias, D. T., Boesteanu, A. C., Fraietta, J. A., Hope, J. L., Carey, A. J., Mueller, Y. M., Kawalekar, O. U., Fike, A. J., June, C. H., & Katsikis, P. D. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501890 · Cited by 30
“Frequencies of (D) IFN-g+, (E) TNF-a+, and (F) granzyme B+ CD8+ T cells in day 10 influenza virus infections (top) and day 7 L. monocytogenes infections (bottom) are shown.”
BackgroundInfluentialTumor hypermetabolism confers resistance to immunotherapy
Liu, A. J., & Curran, M. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.009 · Cited by 29
Nicoli, F., Paul, S., & Appay, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02372 · Cited by 33
The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy
Ganjoo, S., Gupta, P., Corbali, H. I., Nanez, S., Riad, T. S., Duong, L. K., Barsoumian, H. B., Masrorpour, F., Jiang, H., Welsh, J. W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172931 · Cited by 35
Glucose-dependent glycosphingolipid biosynthesis fuels CD8+ T cell function and tumor control
Longo, J., DeCamp, L. M., Oswald, B. M., Teis, R., Reyes-Oliveras, A., Dahabieh, M. S., Ellis, A. E., Vincent, M. P., Damico, H., Gallik, K. L., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.07.006 · Cited by 35
Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?
Sayed, R. E., Haibe, Y., Amhaz, G., Bouferraa, Y., & Shamseddine, A. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042142 · Cited by 30
Mangal, J. L., Handlos, J. L., Esrafili, A., Inamdar, S., Mcmillian, S., Wankhede, M., Gottardi, R., & Acharya, A. P. (2021) · Cancers · doi:10.3390/cancers13051123 · Cited by 28
“Interestingly, studies suggest that cancer cells outcompete T cells for glucose in vivo in cancerous mouse models, therefore preventing the cytokine production that is required for T cells to mount a cellular response against the tumor (Figure 2A) [50,62].”
BackgroundKrug, A., Martinez-Turtos, A., & Verhoeyen, E. (2021) · Cancers · doi:10.3390/cancers14010183 · Cited by 32
“Additionally, the byproduct lactate is extremely immunosuppressive, which leads to the acidification of the tumor environment [50–52], weakening CD8+ T cell effector functions, proliferation and cytokine production both in the murine and human context [53,54].”
BackgroundT Cell–Expressed microRNA-155 Reduces Lifespan in a Mouse Model of Age-Related Chronic Inflammation
Ekiz, H. A., Ramstead, A. G., Lee, S.-H., Nelson, M. C., Bauer, K. M., Wallace, J. A., Hu, R., Round, J. L., Rutter, J. P., Drummond, M. J., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901484 · Cited by 27
“Although it is widely accepted that activated T cells require higher glycolytic activity to support proliferation and effector cytokine production (65, 72, 73), our data demonstrate that skewing T cell metabolism toward aerobic glycolysis by deleting Mpc1 is sufficient to promote their activation in the context of age…”
BackgroundMetabolic control of type 2 immunity
Pelgrom, L. R., & Everts, B. (2017) · European Journal of Immunology · doi:10.1002/eji.201646728 · Cited by 27
Immunometabolism: A ‘Hot’ Switch for ‘Cold’ Pediatric Solid Tumors
Xiao, L., Yeung, H., Haber, M., Norris, M. D., & Somers, K. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.05.002 · Cited by 26
Inhibition of the lymphocyte metabolic switch by the oxidative burst of human neutrophils
Kramer, P. A., Prichard, L. E., Chacko, B. K., Ravi, S., Overton, E. T., Heath, S. L., & Darley-Usmar, V. M. (2015) · Clinical Science · doi:10.1042/cs20140852 · Cited by 27
Bahadoran, A., Bezavada, L., & Smallwood, H. S. (2020) · Immunological Reviews · doi:10.1111/imr.12851 · Cited by 28
Glucose transport in lymphocytes
Lang, F. J. W., Singh, Y., Salker, M. S., Ma, K., Pandyra, A. A., Lang, P. A., & Lang, K. S. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02416-y · Cited by 29
Single cell metabolic imaging of tumor and immune cells in vivo in melanoma bearing mice
Heaton, A. R., Rehani, P. R., Hoefges, A., Lopez, A. F., Erbe, A. K., Sondel, P. M., & Skala, M. C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1110503 · Cited by 23
“In contrast, NKT cells suppress glycolysis in the TME and rely on enhanced oxidative phosphorylation for function (81, 82).”
BackgroundInfluentialThe “sweet” path to cancer: focus on cellular glucose metabolism
Iacobini, C., Vitale, M., Pugliese, G., & Menini, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1202093 · Cited by 27
“Like the pro-inflammatory CD4+ Th17 cells, CD8+ lymphocytes require a Warburg-like metabolism not only for their proliferative capacity, but also for their effector functions (53, 54).”
BackgroundThe Cytotoxic T Lymphocyte Assay for Evaluating Cell-Mediated Immune Function
Burleson, G. R., BURLESON, F. G., & Dietert, R. R. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-401-2_14 · Cited by 24
Sensitivity to Restimulation-Induced Cell Death Is Linked to Glycolytic Metabolism in Human T Cells
Larsen, S. E., Bilenkin, A., Tarasenko, T. N., Arjunaraja, S., Stinson, J. R., McGuire, P. J., & Snow, A. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601218 · Cited by 24
“For proliferating T cells, glycolysis is not only employed for macromolecule synthesis, but is also critical for acquiring full effector functions (3, 6, 24, 25).”
BackgroundMetabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy
Dastmalchi, F., Deleyrolle, L. P., Karachi, A., Mitchell, D. A., & Rahman, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.691246 · Cited by 24
“Conversely, immunosuppressive regulatory T cells (Tregs) that are a subset of CD4+ T cells have lower needs for glycolysis that leads to less consumption of glucose and glutamine and less production of lactate compared to effector T cells (80).”
BackgroundTumor metabolism rewiring in epithelial ovarian cancer
Wang, M., Zhang, J., & Wu, Y. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01196-0 · Cited by 33
Chakhtoura, M., Chain, R. W., Sato, P. Y., Qiu, C. C., Lee, M. H., Meissler, J. J., Eisenstein, T. K., Koch, W. J., Caricchio, R., & Gallucci, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00030 · Cited by 23
“We propose that EP has a stronger effect on the protein rather than mRNA level for specific targets, as similarly shown with the glycolysis inhibitor 2-deoxyglucose (2-DG), possibly because energy demanding expansion of the ER and Golgi is required for protein translation (48).”
Yang, J., He, J., Feng, Y., & Xiang, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166440 · Cited by 29
mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB
Finlay, D. K. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120359 · Cited by 25
Fatty Acid Metabolism and T Cells in Multiple Sclerosis
Pompura, S. L., Hafler, D. A., & Dominguez‐Villar, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869197 · Cited by 26
Metabolic regulation of immune responses to cancer
Wißfeld, J., Werner, A., Yan, X., ten Bosch, N., & Cui, G. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0381 · Cited by 27
Modulation of T cell function and survival by the tumor microenvironment
Mani, N. L., Andrews, D., & Obeng, R. C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1191774 · Cited by 22
“This switch in metabolism is required for the high energy demands for T cell expansion and the production of effector molecules such as IL-2, IFNγ, and granzyme B (Cham et al., 2008; Chang et al., 2015).”
BackgroundAnderson, K. G., Braun, D. A., Buqué, A., Gitto, S. B., Guerriero, J. L., Horton, B. L., Keenan, B. P., Kim, T. S., Overacre-Delgoffe, A. E., Ruella, M., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006533 · Cited by 24
Metabolic manipulation of the tumour immune microenvironment
Wan, M., Ding, Y., Li, Z., Wang, X., & Xu, M. (2021) · Immunology · doi:10.1111/imm.13444 · Cited by 22
Expression of JAK3 Sensitive Na+ Coupled Glucose Carrier SGLT1 in Activated Cytotoxic T Lymphocytes
Bhavsar, S. K., Singh, Y., Sharma, P., Khairnar, V., Hosseinzadeh, Z., Zhang, S., Palmada, M., Sabolić, I., Koepsell, H., Lang, K. S., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447827 · Cited by 21
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications
Indini, A., Grossi, F., Mandalà, M., Taverna, D., & Audrito, V. (2021) · Biomedicines · doi:10.3390/biomedicines9060607 · Cited by 22
“demonstrated that glucose consumption by glycolytic tumors can metabolically restrict T cells, which completely depend on aerobic glycolysis to exert effector activities [91,92], directly dampening their effector function and allowing tumor progression [93].”
BackgroundT cell metabolism in metabolic disease-associated autoimmunity
Amersfoort, J., & Kuiper, J. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.03.001 · Cited by 22
The second genome: Effects of the mitochondrial genome on cancer progression
Scheid, A. D., Beadnell, T. C., & Welch, D. R. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.01.001 · Cited by 22
“Because many tumor cell types also perform aerobic glycolysis, glucose consumption by tumor cells represents a tumor cell intrinsic mechanism by which mtDNA could modulate immunity, where glucose depletion by tumor cells can inhibit effector T cell function (Cham et al., 2008; Chang et al., 2013; Macintyre et al., 201…”
BackgroundElebo, N., Fru, P., Omoshoro–Jones, J., Candy, G. P., & Nweke, E. E. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11622 · Cited by 20
“T-regs depend on oxidative phosphorylation and fatty acid oxidation (Fao) for aTP upon activation (40); this permits T-regs to survive under tumor conditions in contrast to T-eff cells, which are impaired due to insufficient glucose production (41).”
BackgroundThe Natural History of T Cell Metabolism
Braun, M. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136779 · Cited by 20
“These have allowed the identification of metabolic pathways necessary for the function and expansion of T cells, in particular glucose and glutamine [23,34,35].”
BackgroundThe signaling and the metabolic differences of various CAR T cell designs
Razavi, A. S., Loskog, A., Razi, S., & Rezaei, N. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109593 · Cited by 19
Metabolic Challenges in Anticancer CD8 T Cell Functions
Amitrano, A. M., & Kim, M. (2023) · Immune Network · doi:10.4110/in.2023.23.e9 · Cited by 21
“The battle for glucose in the TME between proliferating TILs and cancer cells makes it difficult for T cells to sustain high levels of glycolysis to support proliferation and biosynthesis (85,86).”
BackgroundMougiakakos, D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01166 · Cited by 24
“Consequently, culturing T cells under glucose-deprived conditions severely impedes TCR downstream signaling, proliferation, and cytokine production, leading to an exhausted-like state (29, 30).”
BackgroundThe role of CD8+ T-cells in colorectal cancer immunotherapy
He, T., Hu, C., Li, S., Fan, Y., Xie, F., Sun, X., Jiang, Q., Chen, W., Jia, Y., & Li, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33144 · Cited by 26
New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes
Zhang, M., Zhou, Y., Xie, Z., Luo, S., Zhou, Z., Huang, J., & Zhao, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.914136 · Cited by 23
“NOD mice treated with 2-DG displayed a reduced frequency of activated T cells, decreased immune infiltration within pancreatic islets and increased b-cell granularity (24, 77, 78).”
BackgroundImpact of tumor microenvironment on adoptive T cell transfer activity
Martín-Otal, C., Navarro, F. C., Casares, N., Lasarte-Cía, A., Sánchez-Moreno, I., Hervás‐Stubbs, S., Lozano, T., & Lasarte, J. J. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.03.002 · Cited by 20
Metabolic rewiring directs melanoma immunology
Sun, N., Tian, Y., Chen, Y., Guo, W., & Li, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909580 · Cited by 25
“Nevertheless, in competition with melanoma cells, T cells are deprived of glycolysis, resulting in weakened antitumor function as well as differentiation toward regulatory T cells, which finally triggers melanoma immune evasion (98).”
BackgroundImmunometabolism: a new dimension in immunotherapy resistance
Xiao, C., Xiong, W., Xu, Y., Zou, J. P., Zeng, Y., Liu, J., Peng, Y., Hu, C., & Wu, F. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1012-z · Cited by 20
Resource allocation in mammalian systems
Baghdassarian, H. M., & Lewis, N. E. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108305 · Cited by 17
Metabolism of Immune Cells in the Tumor Microenvironment
Jung, J. G., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_13 · Cited by 20
Aldo-keto reductase 1B: Much learned, much more to do
Zhao, Y., Zhang, M., Li, H., Yang, Y., Lu, X., Yu, J., & Pan, L. (2023) · hLife · doi:10.1016/j.hlife.2023.12.002 · Cited by 19
Yin, S., Li, C., Shen, X., Yu, G., Cui, L., Wu, Y., He, Y., Yu, S., Chen, J., Lu, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202403438 · Cited by 17
Ross, S. H., Rollings, C. M., & Cantrell, D. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712402 · Cited by 17
Metabolic orchestration of T lineage differentiation and function
Yong, C. S. M., Moussa, D. A., Cretenet, G., Kinet, S., Dardalhon, V., & Taylor, N. N. (2017) · FEBS Letters · doi:10.1002/1873-3468.12849 · Cited by 16
The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors
Hunt, E. G., Andrews, A. M., Larsen, S. R., & Thaxton, J. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.867341 · Cited by 18
Metabolic interventions: A new insight into the cancer immunotherapy
Yu, T., Dong, T., Eyvani, H., Fang, Y., Wang, X., Zhang, X., & Lu, X. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108659 · Cited by 16
“Nevertheless, high glucose utilization by cancer cells and endothelial cells out compete immune cells, resulting in reduced INF-ɣ production, Ca2+ dependent pathways, T-cell motility and cytotoxicity and macrophage proinflammatory functions [9, 10, 34, 42].”
BackgroundAoki, T., Nishida, N., & Kudo, M. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554211056853 · Cited by 15
Cui, Y., Sun, Y., Li, D., Zhang, Y., Zhang, Y., Cao, D., & Cao, X. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1275543 · Cited by 20
Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer
Li, Y., Hu, L., Peng, X., Xu, H., Tang, B., & Xu, C. S. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.102 · Cited by 16
Zhang, H., Xu, W., Zhu, H., Chen, X., & Tsai, H. (2024) · Journal of Cancer · doi:10.7150/jca.92502 · Cited by 14
“Aerobic glycolysis plays an important role in activating immune function by CD8 + effector T cells and producing interferons by CD4 + T cells[197, 198].”
BackgroundUnderstanding lymphocyte metabolism for use in cancer immunotherapy
MacPherson, S., Kilgour, M. K., & Lum, J. J. (2018) · FEBS Journal · doi:10.1111/febs.14454 · Cited by 14
Evaluation of Cell-Mediated Immune Function Using the Cytotoxic T-Lymphocyte Assay
Burleson, G. R., BURLESON, F. G., & Dietert, R. R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8549-4_13 · Cited by 13
Loucif, H., Dagenais-Lussier, X., Beji, C., Telittchenko, R., Routy, J., & van Grevenynghe, J. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.02.004 · Cited by 12
Circadian immunometabolism: A future insight for targeted therapy in cancer
Tomar, M. S., Mohit, Kumar, A., & Shrivastava, A. (2024) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2024.102031 · Cited by 16
PHD2 Constrains Antitumor CD8+ T-cell Activity
Donnet, C. B., Acolty, V., Azouz, A., Taquin, A., Henin, C., Cafarello, S. T., Denanglaire, S., Mazzone, M., Oldenhove, G., Léo, O., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0099 · Cited by 14
Peng, Z., Zhang, Y., Ma, X., Zhou, M., Wu, S., Song, Z., Yuan, Y., Chen, Y., Li, Y., Wang, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.728082 · Cited by 13
The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma
Wu, J., Meng, F., Ran, D., Song, Y., Dang, Y., Lai, F., Yang, L., Deng, M., Song, Y., & Zhu, J. (2023) · Metabolites · doi:10.3390/metabo13060734 · Cited by 17
Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation
Noble, J., Jílková, Z. M., Aspord, C., Malvezzi, P., Fribourg, M., Riella, L. V., & Cravedi, P. (2024) · Transplant International · doi:10.3389/ti.2024.12330 · Cited by 13
“Glycolysis inhibition results in cytokine and proliferation impairments in activated CD8 + T cells [81].”
BackgroundImmunometabolism in head and neck squamous cell carcinoma: Hope and challenge
Zhang, Y.-J.-N., Xiao, Y., Li, Z., & Bu, L. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167629 · Cited by 12
Lipids guide T cell antitumor immunity by shaping their metabolic and functional fitness
Rumiano, L., & Manzo, T. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.11.014 · Cited by 13
Aquino, A., & Franzese, O. (2025) · Cancers · doi:10.3390/cancers17091547 · Cited by 13
“Studies suggest that glucose and glutamine deprivation negatively impacts T-cell migration [343], with aerobic glycolysis often identified as the primary ATP source for migration [344].”
Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications
Zhao, D., Li, W., Han, Z., Wang, Z., Li, D., & Li, W. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02696-2 · Cited by 13
“Signi fi cantly, the antitumor effect of CD8 + T cells was reduced when grapevine he was absent [148].”
Khurana, P., Burudpakdee, C., Grupp, S. A., Beier, U. H., Barrett, D. M., & Bassiri, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700374 · Cited by 11
Seasonal Changes in Serum Metabolites in Multiple Sclerosis Relapse
Martynova, E. V., Хайбуллин, Т. И., Salafutdinov, I. I., Markelova, M., Laikov, A. V., Lopukhov, L. V., Liu, R., Sahay, K., Goyal, M., Baranwal, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043542 · Cited by 16
“Additionally, glycolytic reprogramming was demonstrated to be a requirement for CD8+ T cells’ cytokine production and cytotoxic effect [72,73].”
BackgroundSlaats, J., Dieteren, C. E. J., Wagena, E., Wolf, L., Raaijmakers, T. K., van der Laak, J. A. W. M., Figdor, C. G., Weigelin, B., & Friedl, P. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0741 · Cited by 12
Melnik, B. C. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-167-7_37 · Cited by 13
Immunosenescence: Molecular Mechanisms, Diseases, and Therapeutic Innovations
Gong, N., Pan, X., Deng, Y., Che, J., Bao, J., Wang, M., Xu, C., Liu, X., & Shi, Y. (2025) · MedComm · doi:10.1002/mco2.70515 · Cited by 18
Blanchard, R., & Adjei, I. M. (2023) · RSC Advances · doi:10.1039/d3ra01153d · Cited by 11
Metabolic Regulation of T Cell Immunity
Vignali, P., Barbi, J. J., & Pan, F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1170-6_2 · Cited by 11
Galyean, S., Sawant, D., & Shin, A. C. (2020) · Mediators of Inflammation · doi:10.1155/2020/8862034 · Cited by 14
Friedrichs, V., Balkema‐Buschmann, A., Dorhoi, A., & Pei, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-01260-z · Cited by 12
Dotsu, Y., Muraoka, D., Ogo, N., Sonoda, Y., Yasui, K., Yamaguchi, H., Yagita∥, H., Mukae, H., Asai, A., & Ikeda, H. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003958 · Cited by 11
Gill, D., & Tan, P. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.499360 · Cited by 15
“It appears that through regulation of the ability to metabolise glucose, a key fuel for cellular growth and division, CTL effector responses may be controlled indirectly [193].”
BackgroundThe cell identity of cytotoxic T lymphocytes
Sanin, D. E., & Pearce, E. J. (2015) · Nature Immunology · doi:10.1038/ni.3350 · Cited by 10
Garige, M., Ghosh, S., Norris, A. L., Li, G., Poncet, S., Chou, C., Wu, W. W., Shen, R., & Sourbier, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858379 · Cited by 9
“Previous studies have reported that activated CTLs depend on aerobic glycolysis for optimal T effector function (24, 50).”
BackgroundKamnev, A., Mehta, T., Wielscher, M., Chaves, B., Lacouture, C., Mautner, A.-K., Shaw, L. E., Caldera, M., Menche, J., Weninger, W. P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113853 · Cited by 11
Sweet regulation – The emerging immunoregulatory roles of hexoses
Xu, J., Zhao, Y., Mertens, R. T., Ding, Y., & Xiao, P. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.014 · Cited by 12
“In addition, 2-DG also impaired the glycolysis-dependent anti-tumor functions of Th1 cells and CD8 + cytotoxic T lymphocytes (CTLs) [45,200].”
Zhang, R., Jiang, Q., Zhuang, Z., Zeng, H., & Li, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1452303 · Cited by 13
Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses
Shorter, S. K., Schnell, F. J., McMaster, S. R., Pinelli, D. F., Andargachew, R., & Evavold, B. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149582 · Cited by 10
“Additionally, several studies have connected the ability of T cells to produce cytokines with its mode of generating metabolic fuel [34, 54].”
BackgroundStrategies to achieve immune tolerance in allogeneic solid organ transplantation
Zeng, S., Xiao, Z., Wang, Q., Guo, Y., He, Y., Zhu, Q. K., & Zou, Y. (2019) · Transplant Immunology · doi:10.1016/j.trim.2019.101250 · Cited by 12
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
van Genugten, E. A. J., Weijers, J. A. M., Heskamp, S., Kneilling, M., van den Heuvel, M. M., Piet, B., Bussink, J., Hendriks, L. E. L., & Aarntzen, E. H. J. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.786089 · Cited by 15
“Aerobic glycolysis is not required for activation or proliferation during early stages of T-cell activation (98), however, it is essential for optimal T-cell effector function in the TME (99, 100).”
BackgroundXia, Z., Ding, X., Ji, C., Zhou, D., Sun, X., & Liu, T. (2024) · iScience · doi:10.1016/j.isci.2024.108957 · Cited by 8
“19,20 Likewise,thesurfacetraffickingof theglucose transporter Glut1 was critical for sustained T cell activation and the effector function.”
BackgroundZi, R., Shen, K., Zheng, P., Su, X., Yang, Y., Chen, Y., Dai, H., Mao, C., Lu, Y., Wang, L., et al. (2025) · The Innovation · doi:10.1016/j.xinn.2024.100783 · Cited by 14
“…it is well accepted that metabolic reprogramming is a hallmark of cancers critically attributable to the malignant behaviors of cancer cells, 17,18 but why the metabolic characteristics varied across different cancer types and how cancer cells initiate a unique metabolic reprogramming to meet…”
Metabolism and Targeted Therapy of Fibrosis in Chronic Pancreatitis: A Review
Luo, H., Guo, S., Chu, Y., Xin, Y., Yin, X., & Li, X. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.118338 · Cited by 10
“When glucose is scarce, CD8 + T cell function is inhibited, leading to reduced production of IFN-γ, granzyme, and perforin [71, 72].”
Functional and metabolic fitness of human CD4 + T lymphocytes during metabolic stress
Holthaus, L., Sharma, V., Brandt, D., Ziegler, A., Jastroch, M., & Bonifacio, E. E. (2021) · Life Science Alliance · doi:10.26508/lsa.202101013 · Cited by 12
“Murine cytokine-secreting effector T cells are supported by increased glycolytic flux at the epigenetic and posttranscriptional level (Cham et al, 2008; Blagih et al, 2015).”
BackgroundThe expanding Pandora’s toolbox of CD8+T cell: from transcriptional control to metabolic firing
Wu, J., Lü, Z., Zhao, H. C., Lu, M., Gao, Q. S., Che, N., Wang, J., & Ma, T. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04775-3 · Cited by 12
“Glucose deprivation selectively inhibited the production of IFN-γ, granzyme B protein, cyclin D2 protein, cytolytic activity [82, 85].”
BackgroundNew sights of immunometabolism and agent progress in colitis associated colorectal cancer
Zhang, J., Chen, C., Yan, W., & Fu, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1303913 · Cited by 11
Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma
Farah, C., Mignion, L., & Jordan, B. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031725 · Cited by 8
“Moreover, the cytolytic activity of T cells and the IFN-gamma (interferon-gamma) production are regulated by glucose consumption [124].”
BackgroundT-cell Immunometabolism: Therapeutic Implications in Organ Transplantation
Tran, D. T., Sundararaj, K. P., Atkinson, C., & Nadig, S. N. (2021) · Transplantation · doi:10.1097/tp.0000000000003767 · Cited by 12
Metadata
- Authors
- Cham, C. M., Driessens, G., O'Keefe, J. P., & Gajewski, T. F.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Gajewski, Thomas F.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2008-09
- Volume
- 38
- Issue
- 9
- Pages
- 2438-2450
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC3008428
- OpenAlex
- W2156145814
- Cited by
- 388
- References
- 33
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 34 · 2023: 42 · 2022: 34 · 2021: 35 · 2020: 42 · 2019: 24 · 2018: 22 · 2017: 29 · 2016: 21 · 2015: 15 · 2014: 10 · 2013: 8 · 2012: 10
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI47919, R01AI047919)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucose deprivation, CD8+ T cells, effector T cells, glycolysis, 2-deoxyglucose, glucose metabolism, interferon-gamma, GM-CSF, granzyme B, cytotoxicity, gene expression, cell cycle progression, cyclin D2, oxygen deprivation, solid tumors, cell-mediated immunity
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Deoxyglucose, Glucose, Lymphocyte Activation, Oxygen, Gene Expression, Cytokines, CD8-Positive T-Lymphocytes, Gene Expression Profiling, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.